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Background
A high incidence of HIV/AIDS has been observed in Zam-
bia. Current overall estimates stand at 16%.
Method
This was a prospective study done at a Central African
University Teaching Hospital, skin clinic, for five
months.112 KS patients were recruited. Full case histories
and clinical examination were taken and done, respec-
tively.
Results
94.6% of the KS patients were HIV positive whereas 5.4%
were HIV negative. The former had epidemic KS while the
latter had endemic KS. The mean ages for the two types of
KS were 34.9 years(standard deviation = 9.46) for epi-
demic KS and 34.5 years(standard deviation = 14.4) for
endemic KS. The peak incidence of the former type of KS
was in the age range 30 to 39 years whereas for the latter
type it was more or less uniformly distributed in all the
age groups from 10 to 59 years, with a slight peak in the
20 year age range(hence the large standard deviation). The
male(M) to female(F) sex distribution for epidemic KS
was 1.4:1 while for endemic KS it was 2:1. Also, endemic
KS was more common in the low socioeconomic class
unlike the epidemic type which cut across all socioeco-
nomic strata.
Conclusion
1. Most patients with KS have a high prevalence for HIV
Infection (94.6%)
2. The HIV pandemic has led to an increased incidence of
KS in Zambia
3. Epidemic KS (HIV positive) is roughly equally distrib-
uted in both sexes while endemic KS (HIV negative) is
twice more common in males than in females
4. There is no significant difference between the mean age
of epidemic and endemic KS patients
5. Epidemic KS is distributed in all socioeconomic strata
whereas the endemic type is common in the low socioe-
conomic class
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